KDM1A and neoplasm: One study reported that inhibition of LSD1 in B16 melanoma cells was able to increase H3K4me2 levels, leading to dsRNA stress response activation, which triggered an increase in immunogenicity and T-cell infiltration, sensitizing the tumor cells to anti-PD-1 antibody treatment [167].